Abstract:Abstract“Plant bioactive compounds” are secondary metabolites mainly composed of terpenoids, alkaloids, and phenolics that are observed to have varied pharmacological effects in preventing or intervening in human disorders. Due to the great potential of plant secondary metabolites for use in the nutraceutical and pharmaceutical industries, genetic engineering techniques and bioreactor approaches may be efficient ways to mass produce bioactive compounds for industrial use. However, before mass production strategies can be implemented to fulfill industrial needs, a full understanding of the biosynthetic pathways and underlying regulation mechanisms must be gained. The conventional “one enzyme, one gene” study approach is insufficient for elucidating the biosynthetic pathways of most bioactive compounds, especially those of non-model medicinal plants due to lack of available whole genome information. It is foreseen that the emerging “omics” technologies will be useful platforms to provide more global genomics, transcriptomics, proteomics, and metabolomics information to help uncover the biosynthesis pathways of secondary metabolites, especially in medicinal plants. The aim of this review is to summarize the current research progress and knowledge in deciphering the biosynthesis pathways of plant bioactive secondary metabolites selected from the three major compound types using omics approaches.

Deciphering the Biosynthetic Pathways of Bioactive Compounds In Planta Using Omics Approaches